Polysaccharides, mimotopes and vaccines for fungal and encapsulated pathogens
- 1 September 2001
- journal article
- review article
- Published by Elsevier in Trends in Microbiology
- Vol. 9 (9) , 445-451
- https://doi.org/10.1016/s0966-842x(01)02134-5
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Production of Protective Human Antipneumococcal Antibodies by Transgenic Mice with Human Immunoglobulin LociInfection and Immunity, 2000
- A Pneumococcal Capsular Polysaccharide Vaccine Induces a Repertoire Shift with Increased VH3 Expression in Peripheral B Cells from Human Immunodeficiency Virus (HIV)–Uninfected but Not HIV‐Infected PersonsThe Journal of Infectious Diseases, 2000
- Immunoglobulin VH Gene Expression in Human AgingClinical Immunology, 1999
- Anti-CD40 antibody enhances responses to polysaccharide without mimicking T cell helpEuropean Journal of Immunology, 1999
- Aberrant VHGene Utilization in Patients with Established Insulin-Dependent Diabetes MellitusJournal of Autoimmunity, 1997
- Cryptococcus neoformans: Paradigm for the Role of Antibody Immunity Against Fungi?Zentralblatt für Bakteriologie, 1996
- Peptide Libraries Define the Fine Specificity of Anti-polysaccharide Antibodies toCryptococcus neoformansJournal of Molecular Biology, 1996
- Canonical Structure Repertoire of the Antigen-binding Site of Immunoglobulins Suggests Strong Geometrical Restrictions Associated to the Mechanism of Immune RecognitionJournal of Molecular Biology, 1995
- Dispute Slows Paper on "Remarkable" VaccineScience, 1995
- Searching for Peptide Ligands with an Epitope LibraryScience, 1990